Cargando…
NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification
Introduction: Amide Proton Transfer Imaging(APT)is an MRI imaging method that images the increased concentration of amide groups in tumors and is expected to be clinically applied to the diagnostic imaging of gliomas.On the other hand,T2/FLAIR mismatch sign(T2/FLms)has been proposed as an MRI findin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648206/ http://dx.doi.org/10.1093/noajnl/vdab159.078 |
_version_ | 1784610756757553152 |
---|---|
author | Shirota, Masami Nitta, Masayuki Saito, Taiichi Tsuduki, Syunsuke Fukui, Atsushi Ikuta, Souko Yoshida, Ayako Muragaki, Yoshihiro Kawamata, Takakazu |
author_facet | Shirota, Masami Nitta, Masayuki Saito, Taiichi Tsuduki, Syunsuke Fukui, Atsushi Ikuta, Souko Yoshida, Ayako Muragaki, Yoshihiro Kawamata, Takakazu |
author_sort | Shirota, Masami |
collection | PubMed |
description | Introduction: Amide Proton Transfer Imaging(APT)is an MRI imaging method that images the increased concentration of amide groups in tumors and is expected to be clinically applied to the diagnostic imaging of gliomas.On the other hand,T2/FLAIR mismatch sign(T2/FLms)has been proposed as an MRI finding specific to astrocytoma with IDH gene mutation.This time,in the WHO2016 Brain Tumor Pathological Classification,we report the verification of the pathological gene classification of APT and the retrospective verification based on the pathological diagnosis results of whether there is a relationship between APT and T2/FLms. Method: We examined 88 cases of preoperative glioma (Grade:G2/3/4)in which APT/T2/FLAIR was imaged.resultIt showed a high value in high malignancy and a significant difference was observed.In the verification of genetic classification, the measured APT values were 1.91 ±0.71 for oligodendroglioma(16 cases),2.58±0.17 for astrocytoma(2 cases),2.40±0.90 for anaplastic oligodendroglioma(12 cases),Anaplastic astrocytoma(20 cases)2.63±0.42,The oligodendroglioma system showed lower values than the astrocytoma system.For anaplastic astrocytoma IDH mutant and glioblastoma IDH mutant,APT measurement values were measured after evaluating the presence or absence of T2/FL ms. APT measured values are anaplastic astrocytoma IDH mutant T2/FL ms present(7 cases) 2.63±0.38,T2/FL ms not (5 cases) 2.76±0.37, glioblastoma IDH mutant T2/FL ms present(5 cases)2.67±0.50, no T2/FL ms(3 cases)3.48±0.27,suggesting low APT measured values with T2/FL ms,respectively.ConclusionIn the verification of genetic classification, the oligodendroglioma system shows a lower value than the astrocytoma system,and it is considered that it can be one of the options such as treatment policy.Regarding the relationship between T2/FL ms and APT,it was suggested that the APT measured value with T2/FL ms tended to be low,but since it wasreported that the sensitivity of T2/FL ms was 30%,it was verified by accumulating cases.is required. |
format | Online Article Text |
id | pubmed-8648206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-86482062021-12-07 NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification Shirota, Masami Nitta, Masayuki Saito, Taiichi Tsuduki, Syunsuke Fukui, Atsushi Ikuta, Souko Yoshida, Ayako Muragaki, Yoshihiro Kawamata, Takakazu Neurooncol Adv Supplement Abstracts Introduction: Amide Proton Transfer Imaging(APT)is an MRI imaging method that images the increased concentration of amide groups in tumors and is expected to be clinically applied to the diagnostic imaging of gliomas.On the other hand,T2/FLAIR mismatch sign(T2/FLms)has been proposed as an MRI finding specific to astrocytoma with IDH gene mutation.This time,in the WHO2016 Brain Tumor Pathological Classification,we report the verification of the pathological gene classification of APT and the retrospective verification based on the pathological diagnosis results of whether there is a relationship between APT and T2/FLms. Method: We examined 88 cases of preoperative glioma (Grade:G2/3/4)in which APT/T2/FLAIR was imaged.resultIt showed a high value in high malignancy and a significant difference was observed.In the verification of genetic classification, the measured APT values were 1.91 ±0.71 for oligodendroglioma(16 cases),2.58±0.17 for astrocytoma(2 cases),2.40±0.90 for anaplastic oligodendroglioma(12 cases),Anaplastic astrocytoma(20 cases)2.63±0.42,The oligodendroglioma system showed lower values than the astrocytoma system.For anaplastic astrocytoma IDH mutant and glioblastoma IDH mutant,APT measurement values were measured after evaluating the presence or absence of T2/FL ms. APT measured values are anaplastic astrocytoma IDH mutant T2/FL ms present(7 cases) 2.63±0.38,T2/FL ms not (5 cases) 2.76±0.37, glioblastoma IDH mutant T2/FL ms present(5 cases)2.67±0.50, no T2/FL ms(3 cases)3.48±0.27,suggesting low APT measured values with T2/FL ms,respectively.ConclusionIn the verification of genetic classification, the oligodendroglioma system shows a lower value than the astrocytoma system,and it is considered that it can be one of the options such as treatment policy.Regarding the relationship between T2/FL ms and APT,it was suggested that the APT measured value with T2/FL ms tended to be low,but since it wasreported that the sensitivity of T2/FL ms was 30%,it was verified by accumulating cases.is required. Oxford University Press 2021-12-06 /pmc/articles/PMC8648206/ http://dx.doi.org/10.1093/noajnl/vdab159.078 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Supplement Abstracts Shirota, Masami Nitta, Masayuki Saito, Taiichi Tsuduki, Syunsuke Fukui, Atsushi Ikuta, Souko Yoshida, Ayako Muragaki, Yoshihiro Kawamata, Takakazu NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification |
title | NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification |
title_full | NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification |
title_fullStr | NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification |
title_full_unstemmed | NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification |
title_short | NI-16 Verification of APT image and relationship with T2/FLAIR mismatch sign in WHO2016 brain tumor pathology classification |
title_sort | ni-16 verification of apt image and relationship with t2/flair mismatch sign in who2016 brain tumor pathology classification |
topic | Supplement Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648206/ http://dx.doi.org/10.1093/noajnl/vdab159.078 |
work_keys_str_mv | AT shirotamasami ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification AT nittamasayuki ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification AT saitotaiichi ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification AT tsudukisyunsuke ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification AT fukuiatsushi ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification AT ikutasouko ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification AT yoshidaayako ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification AT muragakiyoshihiro ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification AT kawamatatakakazu ni16verificationofaptimageandrelationshipwitht2flairmismatchsigninwho2016braintumorpathologyclassification |